COVID-19: Healcloud’s EMR extraction software given to hospitals at cost to find a cure
COVID-19: Healcloud’s EMR extraction software given to hospitals at cost to find a cure
April 27th, 2020, by Healcloud
Combating SARS-CoV-2 is creating unimagined clinical challenges for our health networks. With over 2.9 million confirmed cases world-wide, and 200,000 dead, Healcloud is offering its electronic medical records (EMR) extraction software to hospitals and institutions world-wide at the forefront of fighting the global pandemic, empowering them with more current and granular data for research and management in the pursuit of a vaccine and cure.
We are offering our unique research intelligence solution used across hospital networks to enable rapid epidemiological and resource monitoring and management, identify and shortlist patients for interventional trials, as well as support health economics and outcomes research and population health analytics for institutions and governments.
Healinsight Enterprise enables researchers and administrators to rapidly query and analyze longitudinal health graphs and aggregate data – for COVID-19, indeed any disease – optimized for the data models they are accustomed, extracted directly from a clinical site’s EMR system in a manner that is legally compliant, auditable, system agnostic, and anonymized to ISO standards. Healinsight Enterprise supports both structured data from national and international codebases – as well as unstructured free text. Healinsight Enterprise unites myriad data sources into one data-rich public standard – with full GDPR compliance.
Further, while there are several pandemic assessment tools which monitor outbreaks and resource availability, none are connected directly to current, near real-time medical data, and none are scalable to such an extent as Healinsight, enabling the direct and constant tracking of the development of symptoms and disease progression across a nation or region.
At Healcloud, driving better health through better data is our mission. With over 320 clinical trials actively recruiting for COVID-19 patients today, we are honored to be in a position to offer our technology and help institutions generate the real-world data they need in order to increase the odds of success for society.
If you or your organization are interested, please get in touch to discuss the discount and terms of this offer at enquiries@healcloud.com.
April 27th, 2020, by Healcloud
Combating SARS-CoV-2 is creating unimagined clinical challenges for our health networks. With over 2.9 million confirmed cases world-wide, and 200,000 dead, Healcloud is offering its electronic medical records (EMR) extraction software to hospitals and institutions world-wide at the forefront of fighting the global pandemic, empowering them with more current and granular data for research and management in the pursuit of a vaccine and cure.
We are offering our unique research intelligence solution used across hospital networks to enable rapid epidemiological and resource monitoring and management, identify and shortlist patients for interventional trials, as well as support health economics and outcomes research and population health analytics for institutions and governments.
Healinsight Enterprise enables researchers and administrators to rapidly query and analyze longitudinal health graphs and aggregate data – for COVID-19, indeed any disease – optimized for the data models they are accustomed, extracted directly from a clinical site’s EMR system in a manner that is legally compliant, auditable, system agnostic, and anonymized to ISO standards. Healinsight Enterprise supports both structured data from national and international codebases – as well as unstructured free text. Healinsight Enterprise unites myriad data sources into one data-rich public standard – with full GDPR compliance.
Further, while there are several pandemic assessment tools which monitor outbreaks and resource availability, none are connected directly to current, near real-time medical data, and none are scalable to such an extent as Healinsight, enabling the direct and constant tracking of the development of symptoms and disease progression across a nation or region.
At Healcloud, driving better health through better data is our mission. With over 370 clinical trials actively recruiting for COVID-19 patients today, we are honored to be in a position to offer our technology and help institutions generate the real-world data they need in order to increase the odds of success for society.
If you or your organization are interested, please get in touch to discuss the discount and terms of this offer at enquiries@healcloud.com.